id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-1845-0137,FDA,FDA-2019-N-1845,Fixed-Quantity Blister Packaging of Opioid Analgesics:  Rationale to Support Specific Packaging Sizes - Slides,Supporting & Related Material,Background Material,2020-12-02T05:00:00Z,2020,12,,,2021-02-11T17:52:22Z,,0,0,0900006484984216
FDA-2019-N-1845-0136,FDA,FDA-2019-N-1845,"Fixed-Quantity Unit-of-Use Blister-Packaging for Certain Immediate-
Release Opioid Analgesics for Treatment of Acute Pain; Establishment of a Public Docket; Request for Comments; Reopening of the Comment  Period and Provision of Additional Information and Analysis",Notice,Request for Comments,2020-12-01T05:00:00Z,2020,12,2020-12-01T05:00:00Z,2021-02-02T04:59:59Z,2021-02-02T02:00:58Z,2020-26504,0,0,090000648497f5d1
FDA-2019-N-1845-0001,FDA,FDA-2019-N-1845,"Fixed-Quantity Unit-of-Use Blister Packaging for Certain Immediate-
Release Opioid Analgesics for Treatment of Acute Pain; Establishment of a Public Docket; Request for Comments",Notice,Request for Comments,2019-05-31T04:00:00Z,2019,5,2019-05-31T04:00:00Z,2019-07-31T03:59:59Z,2021-02-18T02:00:45Z,2019-11283,0,0,0900006483cdb184